169 related articles for article (PubMed ID: 33859162)
1. Malignant pleural mesothelioma co-opts BCL-X
Xu D; Liang SQ; Yang Z; Yang H; Bruggmann R; Oberhaensli S; Berezowska S; Marti TM; Hall SRR; Dorn P; Kocher GJ; Schmid RA; Peng RW
Cell Death Dis; 2021 Apr; 12(4):406. PubMed ID: 33859162
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling.
Surman DR; Xu Y; Lee MJ; Trepel J; Brown K; Ramineni M; Splawn TG; Diggs LP; Hodges HC; Davis JL; Lee HS; Burt BM; Ripley RT
Mol Cancer Ther; 2021 Aug; 20(8):1469-1480. PubMed ID: 34088830
[TBL] [Abstract][Full Text] [Related]
3. The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma.
Arulananda S; Lee EF; Fairlie WD; John T
Expert Rev Anticancer Ther; 2021 Apr; 21(4):413-424. PubMed ID: 33238762
[No Abstract] [Full Text] [Related]
4. Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts.
Littlejohn JE; Cao X; Miller SD; Ozvaran MK; Jupiter D; Zhang L; Rodarte C; Smythe WR
Int J Cancer; 2008 Jul; 123(1):202-8. PubMed ID: 18360826
[TBL] [Abstract][Full Text] [Related]
5. Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma.
Potter DS; Du R; Bohl SR; Chow KH; Ligon KL; Bueno R; Letai A
Nat Commun; 2023 May; 14(1):2897. PubMed ID: 37210412
[TBL] [Abstract][Full Text] [Related]
6. A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma.
Arulananda S; O'Brien M; Evangelista M; Jenkins LJ; Poh AR; Walkiewicz M; Leong T; Mariadason JM; Cebon J; Balachander SB; Cidado JR; Lee EF; John T; Fairlie WD
Cell Death Discov; 2021 May; 7(1):122. PubMed ID: 34050131
[TBL] [Abstract][Full Text] [Related]
7. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W
Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118
[TBL] [Abstract][Full Text] [Related]
8. A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity.
Ponassi R; Biasotti B; Tomati V; Bruno S; Poggi A; Malacarne D; Cimoli G; Salis A; Pozzi S; Miglino M; Damonte G; Cozzini P; Spyrakis F; Campanini B; Bagnasco L; Castagnino N; Tortolina L; Mumot A; Frassoni F; Daga A; Cilli M; Piccardi F; Monfardini I; Perugini M; Zoppoli G; D'Arrigo C; Pesenti R; Parodi S
Cell Cycle; 2008 Oct; 7(20):3211-24. PubMed ID: 18843207
[TBL] [Abstract][Full Text] [Related]
9. BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.
Arulananda S; O'Brien M; Evangelista M; Harris TJ; Steinohrt NS; Jenkins LJ; Walkiewicz M; O'Donoghue RJJ; Poh AR; Thapa B; Williams DS; Leong T; Mariadason JM; Li X; Cebon J; Lee EF; John T; Fairlie WD
Cell Death Discov; 2020 Oct; 6(1):114. PubMed ID: 33298868
[TBL] [Abstract][Full Text] [Related]
10. Mesothelioma Cells Depend on the Antiapoptotic Protein Bcl-xL for Survival and Are Sensitized to Ionizing Radiation by BH3-Mimetics.
Jackson MR; Ashton M; Koessinger AL; Dick C; Verheij M; Chalmers AJ
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):867-877. PubMed ID: 31786278
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Bcl-xL enhances growth-inhibiting and apoptosis-inducing effects of resveratrol and clofarabine in malignant mesothelioma H-2452 cells.
Lee YJ; Hwang IS; Lee YJ; Lee CH; Kim SH; Nam HS; Choi YJ; Lee SH
J Korean Med Sci; 2014 Nov; 29(11):1464-72. PubMed ID: 25408576
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
Varin E; Denoyelle C; Brotin E; Meryet-Figuière M; Giffard F; Abeilard E; Goux D; Gauduchon P; Icard P; Poulain L
Carcinogenesis; 2010 Jun; 31(6):984-93. PubMed ID: 20142415
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.
Ozvaran MK; Cao XX; Miller SD; Monia BA; Hong WK; Smythe WR
Mol Cancer Ther; 2004 May; 3(5):545-50. PubMed ID: 15141012
[TBL] [Abstract][Full Text] [Related]
14. Manumycin A induces apoptosis in malignant pleural mesothelioma through regulation of Sp1 and activation of the mitochondria-related apoptotic pathway.
Kim KH; Chae JI; Oh H; Cho JH; Lee RH; Yoon G; Cho SS; Cho YS; Lee MH; Liu K; Lee HJ; Shim JH
Oncol Rep; 2016 Jul; 36(1):117-24. PubMed ID: 27176604
[TBL] [Abstract][Full Text] [Related]
15. JSI-124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma.
Zhang C; Sun Q; Zhao J; Jiang N; Hao Y; Luo J; Karim S; Wu L; de Perrot M; Peng C; Zhao X
Mol Carcinog; 2023 Dec; 62(12):1888-1901. PubMed ID: 37642305
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL.
Cao XX; Mohuiddin I; Chada S; Mhashilkar AM; Ozvaran MK; McConkey DJ; Miller SD; Daniel JC; Smythe WR
Mol Med; 2002 Dec; 8(12):869-76. PubMed ID: 12606823
[TBL] [Abstract][Full Text] [Related]
17. The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress Beclin 1/Atg6-mediated lethal autophagy in polyploid cells.
Zhang J; Zhang S; Shi Q; Allen TD; You F; Yang D
Exp Cell Res; 2020 Sep; 394(1):112112. PubMed ID: 32473226
[TBL] [Abstract][Full Text] [Related]
18. BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer.
Ramesh P; Di Franco S; Atencia Taboada L; Zhang L; Nicotra A; Stassi G; Medema JP
Cell Rep; 2022 Feb; 38(7):110374. PubMed ID: 35172148
[TBL] [Abstract][Full Text] [Related]
19. Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.
Pécot J; Maillet L; Le Pen J; Vuillier C; Trécesson SC; Fétiveau A; Sarosiek KA; Bock FJ; Braun F; Letai A; Tait SWG; Gautier F; Juin PP
Cell Rep; 2016 Dec; 17(12):3347-3358. PubMed ID: 28009301
[TBL] [Abstract][Full Text] [Related]
20. Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
Cakiroglu E; Senturk S
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
